China Universal Asset Management Company’s Indivior Pharmaceuticals INDV Stock Holding History

China Universal Asset Management Company’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$796K	Sell	19,404 -2,790	-13%	-$101K	0.05%	226
2026 Q1	$676K	Buy	22,194 +1,849	+9%	+$61.1K	0.05%	235
2025 Q4	$730K	Sell	20,345 -1,525	-7%	-$46.6K	0.06%	214
2025 Q3	$527K	Sell	21,870 -3,189	-13%	-$66.7K	0.04%	241
2025 Q2	$369K	Buy	25,059 +159	+0.6%	+$1.85K	0.03%	267
2025 Q1	$237K	Sell	24,900 -4,006	-14%	-$42.1K	0.02%	296
2024 Q4	$359K	Buy	+28,906	New	+$297K	0.03%	280

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

China Universal Asset Management Company's INDV Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Indivior Pharmaceuticals (INDV) stake by 13% in Q2 2026, selling an estimated $101K and leaving 19,404 shares worth $796K. The position accounts for 0.05% of the portfolio, ranked #226.

China Universal Asset Management Company first reported a position in INDV in Q4 2024 and has held it in 7 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

China Universal Asset Management Company held 19,404 shares of Indivior Pharmaceuticals worth $796K as of Q2 2026.
China Universal Asset Management Company sold 2,790 Indivior Pharmaceuticals shares in Q2 2026, an estimated $101K.
Indivior Pharmaceuticals made up 0.05% of China Universal Asset Management Company's portfolio in Q2 2026, its #226 holding.
China Universal Asset Management Company first reported a position in Indivior Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.